US Patent 8809051 Transgenic mammals having human Ig loci including plural V

Patent 8809051 was granted and assigned to Amgen on August, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88090510

Patent Inventor Names

Raju Kucherlapati0

Susan Klapholz0

Aya Jakobovits0

Larry Green0

Michael J Mendez0

Date of Patent

August 19, 2014

Patent Application Number

118947790

Date Filed

August 20, 2007

Patent Citations Received

‌

US Patent 12129305 Targeting CLPTM1L for treatment and prevention of cancer

‌

US Patent 11759527 Anti-EGFR antibody-drug conjugates

Patent Primary Examiner

‌

Anne Marie S. Wehbe′

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8809051 Transgenic mammals having human Ig loci including plural V

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API